Skip to main content
2025 CRT Conference Main banner
Back

CRT 2025

Technology and Innovation

MedTech Town Hall

Panel Discussion

Tuesday, March 11, 2025
10:30 AM – 10:50 AM ET

    Panel Moderator(s)

  • LB

    Lawrence Biegelsen

    Managing Director Medical Supplies & Devices
    Wells Fargo

    Disclosure information not submitted.

  • Rick Wise, MA

    Stifel
    New York, NY, United States

    Disclosure information not submitted.

    • Panel Discussant(s)

  • William T. Abraham, MD

    Professor of Medicine
    The Ohio State University
    Columbus, Ohio, United States

    Disclosure information not submitted.

  • Dominic Allocco, MD, MS

    Associate Chief Medical Officer
    Shockwave/Johnson & Johnson, Minnesota, United States

    Disclosure(s): Boston Scientific: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave/Johnson&Johnson: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

  • Steven R. Bailey, MD, MSCAI

    Professor of Medicine
    LSU Health Shreveport
    San Antonio, Texas, United States

    Disclosure information not submitted.

  • Rafael Cavalcante, MD, PhD

    Vice President, Medical Affairs
    Boston Scientific
    Newton, Massachusetts, United States

    Disclosure information not submitted.

  • Samuel Conaway, MBA

    President Cardiology Sales
    Boston Scientific Corporation

    Disclosure information not submitted.

  • Megan Coylewright, MD, MPH

    Editor
    American College of Cardiology CardioSmart, Tennessee, United States

    Disclosure(s): Alleviant Medical: Consultant (Ongoing); Boston Scientifiic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consultant (Ongoing); Medtronic: Consultant (Ongoing)

  • Haim Danenberg, MD

    Head of interventional cardiology
    Wolfson Medical Center
    Holon, Israel

    Disclosure information not submitted.

  • JF

    Jason Fontana, PhD

    Vice President Marketing and Strategy
    Medtronic, California, United States

    Disclosure information not submitted.

  • Aaron V. Kaplan, MD, FSCAI, FACC, FNAI

    Professor of Medicine
    Dartmouth Health Geisel School of Medicine at Dartmouth
    Lebanon, New Hampshire, United States

    Disclosure information not submitted.

  • Devi G. Nair, MD , FACC, FHRS

    Director of Cardiac Electrophysiology
    St. Bernards Medical Center
    JONESBORO, Arkansas, United States

    Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Jeffrey J. Popma, MD

    CRF
    Newton, Massachusetts, United States

    Disclosure information not submitted.

  • Patrick W. Serruys, MD, PhD

    Professor of Medical Intervention & Innovation
    University of Galway, Ireland

    Disclosure information not submitted.

  • Charles A. Simonton, MD, FACC, FSCAI

    EVP Chief Medical Officer
    Abiomed a Johnson + Johnson MedTech Company
    Charlotte, North Carolina, United States

    Disclosure(s): Johnson and Johnson: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing)

  • Nick E. West, MA MD FRCP FESC FACC

    CMO
    Shockwave Medical
    Santa Clara, California, United States

    Disclosure(s): Shockwave Medical Inc: Employee (Ongoing), Salary (Ongoing)

Disclosure(s):
Dominic Allocco, MD, MS: Boston Scientific: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave/Johnson&Johnson: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Megan Coylewright, MD, MPH: Alleviant Medical: Consultant (Ongoing); Boston Scientifiic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consultant (Ongoing); Medtronic: Consultant (Ongoing)
Devi G. Nair, MD , FACC, FHRS: Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Charles A. Simonton, MD, FACC, FSCAI: Johnson and Johnson: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing)
Nick E. West, MA MD FRCP FESC FACC: Shockwave Medical Inc: Employee (Ongoing), Salary (Ongoing)